Weighted collagen microsponge for immobilizing bioactive materials

• US 4,863,856 A
• Filed: 11/18/1986
• Issued: 09/05/1989
• Est. Priority Date: 04/04/1985
• Status: Expired due to Fees

• Current Assignee: Cellex Life Sciences, Inc.
• Original Assignee: Verax Corporation
• Inventors: Maffia, Gennaro J., Berg, Richard A., Dean, Robert C. Jr., Silver, Frederick H., Phillips, Philip G., Runstadler, Peter W. Jr.
• Primary Examiner(s): Naff, David M.
• Application Number:
  US06/932,088
• Time in Patent Office: 1,022 Days
• Field of Search: 530/356, 435/68, 435/172.1, 435/174, 435/176, 435/177, 435/240.24, 435/240.25, 435/240.26, 435/240.27, 435/252.1, 435/252.3, 436/548, 935/60
• US Class Current: 435/69.1
• CPC Class Codes: C12N 1/00 Microorganisms, e.g. protozoa; Compositions thereof medicinal preparations containing material from protozoa, bacteria or viruses A61K35/66, from algae A61K36/02, from fungi A61K36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K39/00; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
• CPC Class Codes: C12N 11/02 Enzymes or microbial cells immobilised on or in an organic carrier
• CPC Class Codes: C12N 2533/54 Collagen; Gelatin
• CPC Class Codes: C12N 5/0075 using microcarriers
• CPC Class Codes: C12P 1/00 Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes

Abstract

Weighted collagen microsponges having a highly crosslinked collagen matrix are described suitable for use in culturing organisms in motive reactor systems. The microsponges have an open to the surface pore structure, and pore sizes and volumes suitable for immobilizing a variety of bioactive materials. The microsponges also have an average particle size in the range of about 100 to about 1000 microns and a specific gravity above about 1.05.

Claims

1. A method of preparing a weighted collagen microsponge for immobilizing bioactive materials in motive bioreactor systems, said microsponge comprising a porous, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 micron to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05 wherein said weighted collagen microsponge is prepared by the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to produce collagen fibers,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) thermally soaking said solid particles by holding said particles at a temperature at which said particles remain frozen and for a period of time and under conditions sufficient to allow partial agglomeration of said collagen fibers to occur,

(g) vacuum drying said solid particles into a dry, porous matrix, and

(h) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge.

2. The method of claim 1 wherein said thermal soaking is at -5°

C. to -60°

C. for 2 to 48 hours.

3. The method of claim 2 wherein said thermal soaking is at -10°

C. to -20°

C. for 3 to 24 hours.

4. The method of claim 3 wherein said thermal soaking is at -14°

C. for 4 hours.

6. The method as in any of claims 1 or 5 wherein said collagen is milled to obtain fibers having a length of less than 200 microns and a diameter of less than 1.0 micron.

7. The method as in any of claims 1 or 5 wherein said admixture has a pH less than 5.0.

8. The method of claim 7 wherein said admixture has a pH less than 3.0.

9. The method as in any of claims 1 or 5 wherein said weighted collagen microsponge is contacted with bioactive material selected from the group consisting of enzymes, microorganisms, and cells of higher organisms to immobilize said bioactive material.

10. The method as in any of claims 1 or 5 wherein said inert weighting material is added into said mixture of collagen and acidic liquid medium as a finely divided powder.

11. The method of claim 10 wherein said collagen is Type I.

12. The method of claim 11 wherein said Type I collagen is selected from the group consisting of tendon collagen and corium collagen.

13. The method as in any of claims 1 or 5 wherein said inert weighting material is selected from the group consisting of metals, metal alloys, metal oxides and ceramics.

14. The method of claim 13 wherein said weighting material has a specific gravity of above about 4.0 and said microsponge has a specific gravity of above about 1.3.

15. The method of claim 14 wherein said inert weighting material is dispersed throughout said collagen matrix as finely divided powder.

16. The method of claim 14 wherein said weighting material is centrally disposed as a solid core about which said collagen matrix is formed.

17. The method of claim 14 wherein said inert weighting material is selected from the group consisting of chromium, tungsten, cobalt, molybdenum, titanium, nickel and alloys thereof.

18. The method of claim 17 wherein said alloy is 316 stainless steel.

19. The method of claim 17 wherein said weighting material is an alloy and said alloy is 316 stainless steel and said microsponge is contacted with hybridoma cells to immobilized the cells therein.

20. The method as in any of claims 1 or 5 wherein said crosslinking of said collagen is by a treatment selected from the group consisting of

(a) contacting said collagen with a crosslinking agent selected from the group consisting of carbodiimides and bifunctional succinimidyl active esters,

(b) subjecting said collagen matrix to elevated temperatures under a vacuum, and

(c) a combination thereof.

21. The method as in any of claims 1 or 5 wherein said vacuum drying is at a pressure less than 4 Torr.

22. The method of claim 21 wherein said vacuum drying is at a pressure less than 3 Torr.

23. The method of claim 22 wherein said vacuum drying is at a pressure less than 0.2 Torr.

24. A weighted collagen microsponge produced by the methods in any of claims 1 or 5.

5. A method of preparing a weighted collagen microsponge for immobilizing bioactive materials in motive bioreactor systems, said microsponge comprising a porous, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the the surface pore structure with an average pore size in the range of from about 1 micron to about 50 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05 wherein said weighted collagen microsponge is prepared by the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to obtain collagen fibers with a diameter less than 1.0 micron,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) vacuum drying said solid particles into a dry porous matrix, and

(g) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge.

25. A bioreactor system comprising a plurality of weighted collagen microsponges, wherein said microsponges have been sterilized and aseptically sealed in a reactor vessel and wherein each of said microsponges comprises a porous, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 micron to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05,

wherein said weighted collagen microsponges are prepared by a method selected from the group consisting of method 1 and method 2,

wherein method 1 comprises the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to produce collagen fibers,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) thermally soaking said solid particles by holding said particles at a temperature at which said particles remain frozen and for a period of time and under conditions sufficient to allow partial agglomeration of said collagen fibers to occur,

(g) vacuum drying said solid particles into a dry, porous matrix, and

(h) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge,

and wherein method 2 comprises the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to obtain collagen fibers with a diameter less than 1.0 micron,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) vacuum drying said solid particles into a dry, porous matrix, and

(g) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge.

26. The biorector system of claim 25 wherein said reactor vessel has a volume between about 0.1 to 10 liters.

27. The bioreactor system of claim 26 wherein said reactor vessel is a fluidized bed reactor vessel having a fluid distribution plate.

28. A process for performing a bioreaction comprising

(a) immobilizing a bioactive material in weighted collagen microsponges;

(b) containing the microsponges having said immobilized bioactive material in a suitable reactor vessel;

(c) passing a liquid reagent stream into said reactor in direct contact with said microsponges;

(d) agitating the mixture of said microsponges and said reagent stream; and

(e) recovering biochemical reaction products from said reactor, wherein each of said microsponges comprises a porous, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 micron to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said micrsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05,

wherein said weighted collagen microsponges are prepared by a method selected from the group consisting of method 1 and method 2,

wherein method 1 comprises the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to produce collagen fibers,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) thermally soaking said solid particles by holding said particles at a temperature at which said particles remain frozen and for a period of time and under conditions sufficient to allow partial agglomeration of said collagen fibers to occur,

(g) vacuum drying said particles into a dry, porous matrix, and

(h) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge, and

wherein method 2 comprises the steps of

(a) milling a source of collagen selected from the group consisting of Types I, II, and III collagen to obtain collagen fibers with a diameter less than 1.0 micron,

(b) admixing said milled collagen with an acidic liquid medium,

(c) adding inert weighting material to said acid/collagen mixture,

(d) producing droplets of the weighted acid/collagen mixture of step (c),

(e) rapidly solidifying said droplets by freezing to form solid particles of a frozen collagen fiber matrix,

(f) vacuum drying said solid particles into a dry porous matrix, and

(g) crosslinking the collagen in said dry, porous matrix to produce said weighted collagen microsponge.

29. The process of claim 28 wherein organisms are the bioactive material immobilized in said microsponges, the microsponges are incubated in said step (d) of agitating the mixture of said microsponges and said reagent stream to promote growth and colonization.

30. The process of claim 28 wherein organisms are the bioactive material immobilized in said microsponges and the recovered product comprises free organisms which have escaped from said microsponges.

31. The process of claim 29 wherein said organisms comprise hybridomas and said product comprises monoclonal antibodies.

32. The process of claim 31 wherein said reactor vessel comprises a fluidized bed reactor vessel.

33. The process of claim 29 wherein said organisms comprise mammalian cells and said products comprise mammalian cell products.

34. The process of claim 29 wherein said organisms are genetically engineered microbial cells and said product comprises secreted protein products.

35. The process of claim 30 wherein said organisms are genetically engineered microbial cells and said product comprises said organisms containing a non-secreted protein product.